The estimated Net Worth of James R Nickel is at least $2.31 Тысяча dollars as of 1 November 2004. James Nickel owns over 2,962 units of VIVUS stock worth over $2,315 and over the last 21 years James sold VVUS stock worth over $0.
James has made over 1 trades of the VIVUS stock since 2004, according to the Form 4 filled with the SEC. Most recently James bought 2,962 units of VVUS stock worth $10,634 on 1 November 2004.
The largest trade James's ever made was buying 2,962 units of VIVUS stock on 1 November 2004 worth over $10,634. On average, James trades about 987 units every 0 days since 2004. As of 1 November 2004 James still owns at least 4,962 units of VIVUS stock.
You can see the complete history of James Nickel stock trades at the bottom of the page.
James's mailing address filed with the SEC is , , , , .
Over the last 21 years, insiders at VIVUS have traded over $6,261,269 worth of VIVUS stock and bought 5,180,746 units worth $13,074,554 . The most active insiders traders include Tide Capital, Llc North Tid..., Alexander J Denner и Ernest Mario. On average, VIVUS executives and independent directors trade stock every 39 days with the average trade being worth of $35,394. The most recent stock trade was executed by John P. Amos on 1 March 2019, trading 11,000 units of VVUS stock currently worth $53,350.
VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.
VIVUS executives and other stock owners filed with the SEC include: